Drug Advertising The pros, cons and caveats
Introduction How bad has it become? Youtube Act 1 Youtube Act 2
 
Spending on drug advertising from 1997 - 2005 Prescription Drugs: Improvements Needed in FDA's Oversight of Direct-to-Consumer Advertising ', GAO report Number GAO-07-54, December 14, 2006 Year Spending on DTC advertising Spending on promotion to physicians Retail value of samples R & D 1997 $1.1 $3.9 $6.0 $15.5 2000 $2.5 $5.6 $8.5 $21.4 2003 $3.3 $7.4 $13.5 $27.1 2004 $4.0 $7.8 $15.9 $29.8 2005 $4.2 $7.2 not available $31.4 Avg annual % increase 19.6 9.0 14.9 9.3 Total % increase, ‘97-’05 296.4 86.0 162.4 103.3
Incentives for refills http://www.fda.gov/cder/ddmac/P3Benzing/sld023.htm
Patient & caregiver tools http://www.fda.gov/cder/ddmac/P3Benzing/sld023.htm
Pros for consumer Educates patients Prompts patients to visit doctor Prompts patients to talk about difficult conditions Can reduce costs by early treatment Might alert patients to a potential disease Empowers consumers to be active in their care
Pros for doctor Facilitates communication with patients Prompts patients to discuss conditions openly Promotes need for MDs to remain educated about drugs Strengthens provider-patient bond
Pros for drug companies Drug companies feel patients have right to know and choose They empower consumers with information They urge patients to seek treatment Can reduce spending on medical services through early treatment and diagnosis
Cons of drug advertising Appeals to emotions Misleading Benefits overstated Understated risks & side effects Influences patients to ask for meds they don’t need Encourages money on brand names
More cons… Sometimes they target a condition that is not a condition (like the spoofs) Undermines physician/patient relationship Bribery from drug companies Consumers lack information on safety & efficacy needed to make a smart decision FDA oversight is weak
http://democracyinaction.org/dia/organizations/commercialalert/campaign.jsp?campaign_KEY=1415&t=stop_drug_ads_home.dwt

Drug advertising for presentation

  • 1.
    Drug Advertising Thepros, cons and caveats
  • 2.
    Introduction How badhas it become? Youtube Act 1 Youtube Act 2
  • 3.
  • 4.
    Spending on drugadvertising from 1997 - 2005 Prescription Drugs: Improvements Needed in FDA's Oversight of Direct-to-Consumer Advertising ', GAO report Number GAO-07-54, December 14, 2006 Year Spending on DTC advertising Spending on promotion to physicians Retail value of samples R & D 1997 $1.1 $3.9 $6.0 $15.5 2000 $2.5 $5.6 $8.5 $21.4 2003 $3.3 $7.4 $13.5 $27.1 2004 $4.0 $7.8 $15.9 $29.8 2005 $4.2 $7.2 not available $31.4 Avg annual % increase 19.6 9.0 14.9 9.3 Total % increase, ‘97-’05 296.4 86.0 162.4 103.3
  • 5.
    Incentives for refillshttp://www.fda.gov/cder/ddmac/P3Benzing/sld023.htm
  • 6.
    Patient & caregivertools http://www.fda.gov/cder/ddmac/P3Benzing/sld023.htm
  • 7.
    Pros for consumerEducates patients Prompts patients to visit doctor Prompts patients to talk about difficult conditions Can reduce costs by early treatment Might alert patients to a potential disease Empowers consumers to be active in their care
  • 8.
    Pros for doctorFacilitates communication with patients Prompts patients to discuss conditions openly Promotes need for MDs to remain educated about drugs Strengthens provider-patient bond
  • 9.
    Pros for drugcompanies Drug companies feel patients have right to know and choose They empower consumers with information They urge patients to seek treatment Can reduce spending on medical services through early treatment and diagnosis
  • 10.
    Cons of drugadvertising Appeals to emotions Misleading Benefits overstated Understated risks & side effects Influences patients to ask for meds they don’t need Encourages money on brand names
  • 11.
    More cons… Sometimesthey target a condition that is not a condition (like the spoofs) Undermines physician/patient relationship Bribery from drug companies Consumers lack information on safety & efficacy needed to make a smart decision FDA oversight is weak
  • 12.